Are Sarcopenia and Cognitive Dysfunction Comorbid After Stroke in the Context of Brain-Muscle Crosstalk?

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2021 Mar 6

PMID 33671531

Citations 5

Authors

Sophia X Sui

Brenton Hordacre

Julie A Pasco

Affiliations

Soon will be listed here.

Abstract

Stroke is a leading cause of death and disability and is responsible for a significant economic burden. Sarcopenia and cognitive dysfunction are common consequences of stroke, but there is less awareness of the concurrency of these conditions. In addition, few reviews are available to guide clinicians and researchers on how to approach sarcopenia and cognitive dysfunction as comorbidities after stroke, including how to assess and manage them and implement interventions to improve health outcomes. This review synthesises current knowledge about the relationship between post-stroke sarcopenia and cognitive dysfunction, including the physiological pathways, assessment tools, and interventions involved.

Citing Articles

Assessing Stroke-Related Sarcopenia in Chronic Stroke: Identification of Clinical Assessment Tools-A Pilot Study.

Arnal-Gomez A, Cortes-Amador S, Ruescas-Nicolau M, Carrasco J, Perez-Alenda S, Santamaria-Balfagon A Biomedicines. 2023; 11(10).

PMID: 37892976 PMC: 10604487. DOI: 10.3390/biomedicines11102601.

Association of Temporalis Muscle Mass with Early Cognitive Impairment in Older Patients with Acute Ischemic Stroke.

Namgung H, Hong S, Choi Y J Clin Med. 2023; 12(12).

PMID: 37373767 PMC: 10299171. DOI: 10.3390/jcm12124071.

Effects of Voluntary Wheel Running Exercise on Chemotherapy-Impaired Cognitive and Motor Performance in Mice.

Lee T, Devaki M, Formolo D, Rosa J, Cheng A, Yau S Int J Environ Res Public Health. 2023; 20(7).

PMID: 37047984 PMC: 10094707. DOI: 10.3390/ijerph20075371.

A Review of the Measurement of the Neurology of Gait in Cognitive Dysfunction or Dementia, Focusing on the Application of fNIRS during Dual-Task Gait Assessment.

Sui S, Hendy A, Teo W, Moran J, Nuzum N, Pasco J Brain Sci. 2022; 12(8).

PMID: 35892409 PMC: 9331540. DOI: 10.3390/brainsci12080968.

Effect of Improvement in Sarcopenia on Functional and Discharge Outcomes in Stroke Rehabilitation Patients.

Matsushita T, Nishioka S, Taguchi S, Yamanouchi A, Okazaki Y, Oishi K Nutrients. 2021; 13(7).

PMID: 34202303 PMC: 8308200. DOI: 10.3390/nu13072192.

References

Sui S, Holloway-Kew K, Hyde N, Williams L, Tembo M, Leach S . Prevalence of Sarcopenia Employing Population-Specific Cut-Points: Cross-Sectional Data from the Geelong Osteoporosis Study, Australia. J Clin Med. 2021; 10(2). PMC: 7831132. DOI: 10.3390/jcm10020343. View

Nagano F, Yoshimura Y, Bise T, Shimazu S, Shiraishi A . Muscle mass gain is positively associated with functional recovery in patients with sarcopenia after stroke. J Stroke Cerebrovasc Dis. 2020; 29(9):105017. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105017. View

Lathuiliere A, Mareschal J, Graf C . How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?. Nutrients. 2019; 11(4). PMC: 6521136. DOI: 10.3390/nu11040881. View

Jeffares I, Merriman N, Rohde D, McLoughlin A, Scally B, Doyle F . A systematic review and meta-analysis of the effects of cardiac rehabilitation interventions on cognitive impairment following stroke. Disabil Rehabil. 2019; 43(6):773-788. DOI: 10.1080/09638288.2019.1641850. View

Gramigna V, Pellegrino G, Cerasa A, Cutini S, Vasta R, Olivadese G . Near-Infrared Spectroscopy in Gait Disorders: Is It Time to Begin?. Neurorehabil Neural Repair. 2017; 31(5):402-412. DOI: 10.1177/1545968317693304. View

Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre A . Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment. Cochrane Database Syst Rev. 2020; 3:CD009628. PMC: 7059964. DOI: 10.1002/14651858.CD009628.pub2. View

Munthe-Kaas R, Aam S, Ihle-Hansen H, Lydersen S, Knapskog A, Wyller T . Impact of different methods defining post-stroke neurocognitive disorder: The Nor-COAST study. Alzheimers Dement (N Y). 2020; 6(1):e12000. PMC: 7085256. DOI: 10.1002/trc2.12000. View

Zietemann V, Kopczak A, Muller C, Wollenweber F, Dichgans M . Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke. Stroke. 2017; 48(11):2952-2957. DOI: 10.1161/STROKEAHA.117.017519. View

Joseph C, Buga A, Vintilescu R, Balseanu A, Moldovan M, Junker H . Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J Cereb Blood Flow Metab. 2012; 32(8):1632-42. PMC: 3421103. DOI: 10.1038/jcbfm.2012.65. View

10.

Ohyama K, Watanabe M, Nosaki Y, Hara T, Iwai K, Mokuno K . Correlation Between Skeletal Muscle Mass Deficit and Poor Functional Outcome in Patients with Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020; 29(4):104623. DOI: 10.1016/j.jstrokecerebrovasdis.2019.104623. View

11.

Fitri F, Fithrie A, Rambe A . Association between working memory impairment and activities of daily living in post-stroke patients. Med Glas (Zenica). 2020; 17(2):433-438. DOI: 10.17392/1135-20. View

12.

Slevin M, Matou S, Zeinolabediny Y, Corpas R, Weston R, Liu D . Monomeric C-reactive protein--a key molecule driving development of Alzheimer's disease associated with brain ischaemia?. Sci Rep. 2015; 5:13281. PMC: 4558604. DOI: 10.1038/srep13281. View

13.

Zhang X, Bi X . Post-Stroke Cognitive Impairment: A Review Focusing on Molecular Biomarkers. J Mol Neurosci. 2020; 70(8):1244-1254. DOI: 10.1007/s12031-020-01533-8. View

14.

Irisawa H, Mizushima T . Correlation of Body Composition and Nutritional Status with Functional Recovery in Stroke Rehabilitation Patients. Nutrients. 2020; 12(7). PMC: 7400130. DOI: 10.3390/nu12071923. View

15.

Podsiadlo D, Richardson S . The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39(2):142-8. DOI: 10.1111/j.1532-5415.1991.tb01616.x. View

16.

Nozoe M, Kanai M, Kubo H, Yamamoto M, Shimada S, Mase K . Prestroke Sarcopenia and Stroke Severity in Elderly Patients with Acute Stroke. J Stroke Cerebrovasc Dis. 2019; 28(8):2228-2231. DOI: 10.1016/j.jstrokecerebrovasdis.2019.05.001. View

17.

Su Y, Yuki M, Otsuki M . Prevalence of stroke-related sarcopenia: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020; 29(9):105092. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105092. View

18.

Guglielmi G, Ponti F, Agostini M, Amadori M, Battista G, Bazzocchi A . The role of DXA in sarcopenia. Aging Clin Exp Res. 2016; 28(6):1047-1060. DOI: 10.1007/s40520-016-0589-3. View

19.

Cabett Cipolli G, Sanches Yassuda M, Aprahamian I . Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis. J Nutr Health Aging. 2019; 23(6):525-531. DOI: 10.1007/s12603-019-1188-8. View

20.

Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View